Replies to post #11324 on Titan Pharmaceuticals Inc (TTNP)

[Doctor Detroit]

Turks...it looks like you were right that the Probuphine Innovations for Clinical Effectiveness (PRINCE) study is ongoing. HITLAB had Dr. Michael Frost, who is running the study, give a presentation at their innovators summit. The conference summary states: "Mike Frost, MD, President and Medical Director, Frost Medical Group, discussed the Prince study, a joint effort by Frost Medical, Braeburn Pharmaceuticals, and HITLAB. The study is exploring the potential utility of actigraphy for physicians in their treatment of opioid dependency, with a specific focus on the medication Probuphine and its effects on patient activity levels and sleep quality."

http://www.hitlab.org/healthy-innovations/

I was curious as to what was going on because the clinical trials page had not been updated. https://clinicaltrials.gov/ct2/show/NCT02896660

I think this is explained because Frost Medical is running the entire 15 person trial. You may recall, Dr. Frost was one of the first doctors to prescribe probuphine.

http://6abc.com/health/local-patients-among-first-in-us-to-receive-new-opioid-addiction-implant/1393858/